Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02616952
Other study ID # 2014S292
Secondary ID
Status Completed
Phase Phase 2
First received November 25, 2015
Last updated March 27, 2018
Start date December 2015
Est. completion date December 2017

Study information

Verified date March 2018
Source Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether Yiqi Suoquan Tang, a Chinese Herbal decoction, is effective in the treatment of female stress urinary incontinence.


Description:

The pilot randomized, controlled trial is aimed to preliminarily assess the effectiveness of Yiqi Suoquan Tang, a Chinese Herbal decoction, in the treatment of female stress urinary incontinence (SUI). Eligible participants will be randomly allocated to receiving Yiqi Suoquan Tang or pelvic floor muscle training (PFMT) using a random number generator in a 1:1 ratio. To minimize the evaluation bias, the outcome assessors and statisticians will be masked to treatment allocation.

Assuming a two-sided alpha of 0.05, power of 90%, and a 20% drop-out, a sample size of 36 would be needed for each group. The statistical analysis will be performed based on the intention-to-treat principle, which is defined as patients that have received at least one treatment. Missing data will be replaced by the last observed value. Continuous variables will be compared by Student t test or Mann-Whitney U test; categorical variables will be analyzed by chi-square test, Fisher's exact test or Kruskal-Wallis H test as appropriate. For comparison between two time points, paired t-test or Wilcoxon signed rank test will be used as appropriate. A statistically significant difference was set at P<0.05.


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers No
Gender Female
Age group 21 Years to 65 Years
Eligibility Inclusion Criteria:

- Clinical diagnosis of stress urinary incontinence

- Must be able to swallow Chinese hebal decoction

Exclusion Criteria:

- Urinary tract infection

- Neurogenic bladder

- Pelvic organ prolapse > stage 2

- Overactive bladder

- Previous anti-incontinence surgery

- Post-void residual urine volume (PVR) > 100ml.

Study Design


Intervention

Dietary Supplement:
Chinese herbal therapy
Participants take a Chinese herbal decoction, Yiqi Suoquan Tang, 200ml orally twice a day for 12 weeks. The Yiqi Suoquan Tang are composed of Radix Astragali 30 g, Radix Codonopsis pilosula 10g, Radix Angelica sinensis 10g, Radix Atractylodis Macrocephalae 10g, Fructus Alpiniae Oxyphyllae 10g, Radix Lindera aggregata 6g, Rhizoma Dioscoreae 10g, pericarpium citri reticulatae 10g, Rhizoma Cimicifuga 10g, Radix Bupleuri 10g, Fructus Rubi 15g, and Semen raphani 10g. All the decoctions are provided by the Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, and are packed in opaque plastic bags with 200 ml for each one.
Behavioral:
Pelvic floor muscle training
In intensive exercises, participants are taught how to identify the muscles: 1) identify anal sphincter/feel anus, and try to raise it from chair (without adding abdominal, thigh, and buttock muscles) with a position of sitting; 2) identify levator ani and try to raise vagina from chair (without adding abdominal, thigh, and buttock muscles) with a position of Sitting, bent forward, elbows on knees; 3) contract levator ani with a position of sitting, lying, and standing; 4) contract anal sphincter with a position of sitting, lying, and standing. Once the participants can identify the muscles, they are asked to do a set consists of 10 contractions, each lasting 5 seconds, with a 5 seconds break between contractions. Then they need to do same procedure 3 times daily as the home exercises.

Locations

Country Name City State
China Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Adverse events 12 weeks
Primary Change in 24h pad testing 12 weeks
Secondary Change in ICIQ-SF questionnaire 12 weeks
Secondary Change in abdominal leak-point pressure 12 weeks
Secondary Change in I-QOL questionnaire 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT02001714 - Group Learning Achieves Decreased Incidents of Lower Urinary Symptoms N/A
Not yet recruiting NCT00523068 - Pharmacological vs Surgical Treatment for Mixed Incontinence Phase 4
Completed NCT00904969 - A Pre-Market Study of the American Medical Systems (AMS) Transobturator Male Sling System for the Treatment of Male Stress Urinary Incontinence N/A
Completed NCT00190827 - Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine) Phase 3
Completed NCT00190814 - Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge. Phase 3
Terminated NCT00247286 - Weighted Vaginal Cones Versus Biofeedback in the Treatment of Urodynamic Stress Incontinence: a Randomized Trial. Phase 4
Completed NCT01959347 - Combined Treatment for Mixed Incontinence Phase 3
Completed NCT00244296 - To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms Phase 4
Not yet recruiting NCT05570071 - A Study of the Use of Vaginal Radiofrequency Therapy in Treatment of SUI. N/A
Completed NCT02334878 - Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence Phase 3
Completed NCT01382602 - Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study Phase 3
Completed NCT03296462 - Hip External Rotation Physical Therapy Trial N/A
Recruiting NCT02750878 - Surgical Consent Process for Trans-obturator Tape Slings. N/A
Completed NCT02296099 - Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence Phase 4
Completed NCT02599051 - Transobturator Verus Single Incision Slings N/A
Completed NCT00138749 - An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence. Phase 2
Terminated NCT03614611 - Canadian Experience With Contiform Intravaginal Device For The Treatment Of Stress Incontinence N/A
Completed NCT03722719 - The Knack on Female Stress Urinary Incontinence N/A
Active, not recruiting NCT02275728 - Pelvic Floor Muscle Training With and Without Biofeedback in Women With Stress Urinary Incontinence N/A
Terminated NCT01358214 - Quality of Life After Tension Free Transvaginal Sling / Tape Operation With a Titanized Surgical Tape (TiLOOP® Tape) N/A